Stan Smith - Mar 20, 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Stock symbol
MAIA
Transactions as of
Mar 20, 2023
Transactions value $
$18,533
Form type
4
Date filed
3/22/2023, 06:42 AM
Previous filing
Mar 13, 2023
Next filing
Mar 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $9.86K +3.01K +0.56% $3.28 536K Mar 20, 2023 See Footnote F1, F2
transaction MAIA Common Stock Purchase $8.67K +2.74K +0.51% $3.17 539K Mar 21, 2023 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F2 The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.18 to $3.345 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F3 The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.10 to $3.57 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.